KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in IntangiblesChange in InventoryDepreciation & Amortization (CF)DivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Gains from Investment Securities (2018 - 2025)

Historic Gains from Investment Securities for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to -$11.2 million.

  • BioNTech SE's Gains from Investment Securities fell 73870.02% to -$11.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$252.9 million, marking a year-over-year increase of 899.51%. This contributed to the annual value of -$415.9 million for FY2024, which is 1995.38% up from last year.
  • Per BioNTech SE's latest filing, its Gains from Investment Securities stood at -$11.2 million for Q3 2025, which was down 73870.02% from -$16.9 million recorded in Q2 2025.
  • BioNTech SE's Gains from Investment Securities' 5-year high stood at $476.2 million during Q2 2023, with a 5-year trough of -$4.0 billion in Q4 2021.
  • In the last 5 years, BioNTech SE's Gains from Investment Securities had a median value of -$16.9 million in 2025 and averaged -$494.5 million.
  • In the last 5 years, BioNTech SE's Gains from Investment Securities crashed by 120027550369638.28% in 2022 and then surged by 15638.89% in 2023.
  • Quarter analysis of 5 years shows BioNTech SE's Gains from Investment Securities stood at -$4.0 billion in 2021, then soared by 64.21% to -$1.4 billion in 2022, then soared by 95.05% to -$70.0 million in 2023, then tumbled by 202.68% to -$212.0 million in 2024, then surged by 94.71% to -$11.2 million in 2025.
  • Its Gains from Investment Securities was -$11.2 million in Q3 2025, compared to -$16.9 million in Q2 2025 and -$12.8 million in Q1 2025.